Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers

NCT01197391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: REGN728

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]